EUVIMEDEUVIMED entdecken
Crossref

Kidney disease associated with inflammatory bowel disease

Federico Yandian, Martina Wild, Lucía Facal

Nefrología Latinoamericana · 02.06.2026

DOI: 10.24875/nefro.25000039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nefrología Latinoamericana, online erschienen am 02.06.2026. Verfasst von Federico Yandian und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, may present extraintestinal manifestations in 5-50% of patients and may be associated with renal and urinary involvement through extraintestinal manifestations, metabolic complications, or drug-related nephrotoxicity.Material and methods: Narrative review focused on renal manifestations associated with inflammatory bowel disease, including tubulointerstitial nephritis, glomerulopathies, nephrolithiasis, and treatment-related renal toxicity.

Results

Renal and urinary involvement has been reported in 4-23% of cases, most commonly as urolithiasis, fistulas, or ureteral obstruction.Parenchymal kidney disease is less frequent and includes IgA nephropathy, tubulointerstitial nephritis, acute tubular necrosis, immune complex-mediated proliferative glomerulonephritis, arteriosclerosis without specific changes, and other glomerular diseases.Kidney biopsy may be required to distinguish drug-induced nephrotoxicity from active extraintestinal renal involvement or concomitant glomerulopathy.

Conclusions

Diagnostic evaluation of renal involvement in inflammatory bowel disease should integrate clinical assessment, laboratory testing, and, when indicated, kidney biopsy.An interdisciplinary approach involving nephrology and gastroenterology is essential to differentiate between drug-induced nephrotoxicity, active extraintestinal manifestations, and concomitant glomerular disease, thereby optimizing renal and overall outcomes.This approach allows continuation of therapies with proven efficacy in controlling chronic intestinal inflammation while minimizing exposure to nephrotoxic agents that may compromise patient survival and quality of life.

Zitieren

APA

Yandian, F., Wild, M., & Facal, L. (2026). Kidney disease associated with inflammatory bowel disease. Nefrología Latinoamericana. https://doi.org/10.24875/nefro.25000039

Vancouver

Yandian F, Wild M, Facal L. Kidney disease associated with inflammatory bowel disease. Nefrología Latinoamericana. 2026. doi:10.24875/nefro.25000039

BibTeX
@article{Yandian2026,
  author = {Yandian, Federico and Wild, Martina and Facal, Lucía},
  title = {Kidney disease associated with inflammatory bowel disease},
  journal = {Nefrología Latinoamericana},
  year = {2026},
  doi = {10.24875/nefro.25000039}
}
Kostenlos starten →